Retinoic Acid, also known as Tretinoin or All-Trans Retinoic Acid (ATRA), stands as a crucial Pharmaceutical Intermediate, valued for its exceptional purity and therapeutic capabilities. With a purity exceeding 99%, this yellow powder form of Vitamin A is a vital component in formulations targeting a spectrum of health concerns, from common dermatological issues to complex hematological malignancies. Understanding the role of this high-purity ingredient is key for anyone in the pharmaceutical development or healthcare sector.

The primary use of Retinoic Acid in dermatology is its potent effect on skin conditions like acne vulgaris. It works by normalizing skin cell turnover, preventing pores from becoming clogged, and reducing inflammation. This makes it an effective treatment for achieving clearer, healthier-looking skin. Its consistent quality and purity ensure predictable and reliable results in topical formulations.

In the critical field of oncology, Retinoic Acid plays a life-saving role, particularly in the treatment of Acute Promyelocytic Leukemia (APL). APL is a severe form of leukemia where immature white blood cells fail to mature into functional cells. Retinoic Acid functions by inducing the differentiation of these leukemic cells, allowing them to mature and eventually undergo programmed cell death. This mechanism has significantly improved survival rates for APL patients, solidifying Retinoic Acid's status as a vital therapeutic agent.

When sourcing Retinoic Acid, the CAS number 302-79-4 serves as a critical identifier for its chemical identity and purity. As a leading supplier of Pharmaceutical Intermediates, we are committed to providing materials that meet the highest global standards. The 2-year shelf life of this yellow powder adds to its practicality for storage and use in manufacturing processes.

For pharmaceutical manufacturers and researchers, the consistent availability of high-purity Retinoic Acid is essential for developing and producing effective treatments. Its broad spectrum of action, from improving skin health to managing aggressive blood cancers, highlights its indispensable nature in the pharmaceutical industry. Investing in the highest grade of Retinoic Acid is an investment in the efficacy and safety of your final products.